Plasma N-terminal Pro-Brain Natriuretic Peptide (Nt-proBNP) level and prognosis after myocardial infarction in diabetes.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Diabetes & Metabolism

• Publication date

  2008-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1262-3636(08)70097-1PMID 18358421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Left atrial enlargement and NT‐proBNP as predictors of sudden cardiac death in patients with heart failure

  2007cited by this paper
• N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction.

  2007cited by this paper
• Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes

  2006cited by this paper
• High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.

  2005cited by this paper
• NT‐proBNP in normoalbuminuric patients with Type 2 diabetes mellitus

  2005cited by this paper
• Increased plasma levels of N-terminal brain natriuretic peptide (NT-proBNP) in type 2 diabetic patients with vascular complications.

  2005cited by this paper
• Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease.

  2004cited by this paper
• Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction.

  2004cited by this paper
• Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria

  2004cited by this paper
• The natriuretic peptides

  2004cited by this paper
• Natriuretic peptides for risk stratification of patients with acute coronary syndromes

  2004cited by this paper
• Essential biochemistry and physiology of (NT‐pro)BNP

  2004cited by this paper
• Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events.

  2004cited by this paper
• Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease.

  2004cited by this paper
• Endothelial function: a critical determinant in atherosclerosis?

  2004cited by this paper
• The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population

  2003influential reference
• N‐Terminal Pro‐Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)‐IV Substudy

  2003cited by this paper
• N-Terminal Pro-B-Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes

  2002influential reference
• Brain Natriuretic Peptide Measurement in Acute Coronary Syndromes: Ready for Clinical Application?

  2002cited by this paper
• Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina

  2000cited by this paper
• Natriuretic peptides.

  1998cited by this paper
• Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.

  1998cited by this paper
• Glucose delivery is a major determinant of glucose utilisation in the ischemic myocardium with a residual coronary flow.

  1998cited by this paper
• The clinical implications of diabetic heart disease.

  1998cited by this paper
• B-type natriuretic peptide: a myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression.

  1998cited by this paper
• Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment

  1997cited by this paper
• Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material

  1992cited by this paper
• Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

  1991cited by this paper
• Noninvasive assessment of cardiomyopathy in normotensive diabetic patients between 20 and 50 years old.

  1989cited by this paper
• The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study.

  1988cited by this paper
• Asymptomatic diabetic cardiomyopathy: a noninvasive study.

  1988cited by this paper

• Simultaneous detection method for two cardiac disease protein biomarkers on a single chip modified with mixed aptamers using surface plasmon resonance.

  2023cites this paper
• Relationship of uric acid, C-reactive protein, and N-terminal pro-B-type natriuretic peptide with acute cerebral infarction.

  2021cites this paper
• The role of natriuretic peptides in diabetes and its complications.

  2016cites this paper
• Effects of a timely therapy with doxycycline on the left ventricular remodeling according to the pre-procedural TIMI flow grade in patients with ST-elevation acute myocardial infarction

  2014cites this paper
• N‐terminal fragment of pro‐brain natriuretic peptide (NT‐proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria

  2010cites this paper
• Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study

  2009cites this paper
• [Diabetes always hits the heart].

  2008cites this paper
• Le diabète frappe toujours au cœur

  2008cites this paper